Workflow
Easttop(002889)
icon
Search documents
深圳市东方嘉盛供应链股份有限公司2025年第三季度报告
Core Viewpoint - The company, Shenzhen Oriental Jiasheng Supply Chain Co., Ltd., has released its third-quarter report for 2025, ensuring that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1][2][7]. Financial Data - The third-quarter financial report has not been audited [3][6]. - The company has made retrospective adjustments to previous accounting data due to a capital reserve conversion completed in May 2025, affecting the earnings per share from the previous year [3][4]. Corporate Governance - The board of directors and the supervisory board have confirmed the authenticity and completeness of the quarterly report, taking legal responsibility for any inaccuracies [2][9]. - The sixth board of directors' seventh meeting was held on October 24, 2025, with all seven directors present, and the meeting complied with legal and regulatory requirements [6][7]. Shareholder Information - The report includes details on the total number of ordinary shareholders and the shareholding status of the top ten shareholders, although specific figures are not provided in the documents [4][5].
东方嘉盛(002889.SZ):第三季度净利润同比上升22.95%
Ge Long Hui A P P· 2025-10-24 11:57
Core Viewpoint - Dongfang Jiasheng (002889.SZ) reported a decline in operating revenue for Q3 2025, while net profit attributable to shareholders increased, indicating mixed financial performance [1] Financial Performance - Operating revenue for Q3 2025 was 789 million yuan, a year-on-year decrease of 22.17% [1] - Net profit attributable to shareholders was 61.5851 million yuan, reflecting a year-on-year increase of 22.95% [1] - Net profit attributable to shareholders after deducting non-recurring gains and losses was 26.4132 million yuan, showing a year-on-year decline of 29.33% [1]
东方嘉盛:10月24日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-10-24 11:32
Group 1 - The core point of the article is that Dongfang Jiasheng (SZ 002889) held its seventh board meeting on October 24, 2025, to review the proposal for the third quarter report of 2025 [1] - For the first half of 2025, Dongfang Jiasheng's revenue composition shows that supply chain management services accounted for 99.88%, while other businesses made up 0.12% [1] - As of the report date, Dongfang Jiasheng has a market capitalization of 5.7 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - There is a discussion on the hot secondary market for biomedicine, while the primary market is facing challenges in fundraising [1]
东方嘉盛:2025年前三季度净利润约1.41亿元
Mei Ri Jing Ji Xin Wen· 2025-10-24 11:24
Group 1 - The core viewpoint of the article highlights the financial performance of Dongfang Jiasheng in Q3 2025, showing a revenue increase but a decline in net profit and earnings per share [1] - Dongfang Jiasheng reported a revenue of approximately 2.898 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 12.63% [1] - The net profit attributable to shareholders was approximately 141 million yuan, reflecting a year-on-year decrease of 21.2% [1] - The basic earnings per share were reported at 0.3757 yuan, which is a decrease of 21.24% compared to the previous year [1] Group 2 - As of the report, Dongfang Jiasheng has a market capitalization of 5.7 billion yuan [2] - The article discusses the broader context of the biopharmaceutical market, noting that China’s innovative drugs have generated 80 billion USD in overseas licensing this year [2] - The conversation with Lu Gang, a partner at Chuangdong Investment, indicates a contrast between the hot secondary market for biopharmaceuticals and the cooling fundraising environment in the primary market [2]
东方嘉盛(002889) - 第六届监事会第七次会议决议公告
2025-10-24 11:15
证券代码:002889 证券简称:东方嘉盛 公告编号:2025-036 深圳市东方嘉盛供应链股份有限公司 二、监事会会议审议情况 (一)、审议通过《关于公司〈2025 年第三季度报告〉的议案》 经审核,监事会认为董事会编制和审核深圳市东方嘉盛供应链股份有限公司 2025 年第三季度报告的程序符合法律、行政法规和中国证监会的规定,报告内 容真实、准确、完整地反映了上市公司的实际情况,不存在任何虚假记载、误导 性陈述或者重大遗漏。 表决结果:3 票同意,0 票反对,0 票弃权。 第六届监事会第七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 深圳市东方嘉盛供应链股份有限公司(以下简称"公司")第六届监事会第 七次会议于 2025 年 10 月 24 日(星期五)在深圳市福田区保税区市花路 10 号东 方嘉盛大厦 6 楼以现场结合通讯的方式召开。会议通知已于 2025 年 10 月 21 日 通过邮件及短信的方式送达各位监事。本次会议应出席监事 3 人,实际出席监事 3 人。 会议由监事会主席何一鸣主持,公司部分高级管理人员列 ...
东方嘉盛(002889) - 第六届董事会第七次会议决议公告
2025-10-24 11:15
(一)审议通过《关于公司〈2025 年第三季度报告〉的议案》 经审议,董事会认为:公司《2025 年第三季度报告》符合法律、行政法规 要求,报告内容真实、准确、完整地反映了公司 2025 年前三季度的经营情况, 不存在虚假记载、误导性陈述或者重大遗漏。 具体内容详见公司披露于巨潮资讯网(http://www.cninfo.com.cn)的《2025 年第三季度报告》(公告编号:2025-037)。 证券代码:002889 证券简称:东方嘉盛 公告编号:2025-035 深圳市东方嘉盛供应链股份有限公司 第六届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导 性陈述或重大遗漏。 一、董事会会议召开情况 深圳市东方嘉盛供应链股份有限公司(以下简称"公司")第六届董事会第 七次会议于 2025 年 10 月 24 日(星期五)在深圳市福田区保税区市花路 10 号东 方嘉盛大厦 6 楼以现场结合通讯的方式召开。会议通知已于 2025 年 10 月 21 日 通过邮件及短信的方式送达各位董事。本次会议应出席董事 7 人,实际出席董事 7 人。 会议由董事孙卫平主持, ...
东方嘉盛(002889) - 2025 Q3 - 季度财报
2025-10-24 11:10
Financial Performance - Q3 2025 revenue was CNY 788.63 million, a decrease of 22.17% compared to the same period last year[5] - Net profit attributable to shareholders was CNY 61.59 million, an increase of 22.95% year-on-year[5] - Basic earnings per share for Q3 2025 was CNY 0.1637, up 22.99% from the previous year[5] - The company's net profit for the current period is ¥145,810,813.91, a decrease of 22% compared to ¥186,839,841.48 in the previous period[20] - The company reported a total comprehensive income of ¥145,747,282.34, down from ¥186,967,808.33, indicating a decline in overall profitability[20] - Basic and diluted earnings per share decreased to ¥0.3757 from ¥0.4770, reflecting lower profitability per share[20] - The company reported a net profit margin improvement, with net profit increasing due to higher investment income of ¥8,058,675.89 compared to ¥17,281,728.82 in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 5.20 billion, reflecting a 9.12% increase from the beginning of the year[5] - Accounts receivable increased by 58.26% to CNY 1.53 billion, primarily due to business growth[9] - Total assets rose to ¥5,201,819,821.82, reflecting a growth of 9.1% from ¥4,767,062,036.48[17] - Total liabilities increased to ¥2,593,235,130.70, a rise of 13.4% compared to ¥2,286,594,068.71[17] - The equity attributable to shareholders of the parent company grew to ¥2,508,097,920.33, up 5.1% from ¥2,385,903,539.98[18] Cash Flow - The company reported a net cash flow from operating activities of CNY 129.32 million, a 33.28% increase compared to the previous year[5] - The net cash flow from operating activities is -¥129,323,690.10, an improvement from -¥193,836,161.00 in the previous period[21] - Cash flow from operating activities improved by 33.28% to -$129.32 million, mainly due to changes in payment transactions[10] - The cash flow from financing activities generated a net inflow of ¥206,262,677.72, down from ¥373,851,021.34, indicating reduced financing activity[22] - The company experienced a decrease in cash inflow from investment activities, with a net cash flow of -¥74,405,865.65 compared to -¥47,758,772.00 previously[21] Investments and Expenditures - Long-term equity investments rose by 40.35% to CNY 90.98 million, attributed to investment expenditures[9] - The company has seen a 56.15% increase in construction in progress, totaling CNY 156.54 million, due to increased investment in warehouse construction[9] - Investment activities generated a cash outflow of $74.41 million, a 55.80% increase due to warehouse construction expenditures[10] - Research and development expenses increased to ¥8,889,835.75, a rise of 27.3% from ¥6,985,060.38 in the previous period[19] Shareholder Information - Total shareholders increased to 30,238, with no preferred shareholders restoring voting rights[12] - The largest shareholder, Sun Weiping, holds 44.54% of shares, totaling 168.22 million shares[13] Other Income and Expenses - Non-operating income for the current period amounted to CNY 35.17 million, down from CNY 39.44 million year-to-date[6] - Financial expenses rose by 39.46% to $10.88 million, mainly due to exchange rate fluctuations and interest expenses[10] - Asset impairment losses increased by 96.85% to $1.25 million, primarily due to changes in accounts receivable[10] - The company reported a significant increase in other income, which rose by 106.34% to $2.00 million, mainly due to changes in fixed asset disposal[10]
东方嘉盛:第三季度净利润6158.51万元,同比增长22.95%
Xin Lang Cai Jing· 2025-10-24 11:08
Core Insights - The company reported a third-quarter revenue of 789 million yuan, a year-on-year decrease of 22.17% [1] - The net profit for the third quarter was 61.5851 million yuan, showing a year-on-year increase of 22.95% [1] - For the first three quarters, the company achieved a revenue of 2.898 billion yuan, reflecting a year-on-year growth of 12.63% [1] - The net profit for the first three quarters was 141 million yuan, which represents a year-on-year decline of 21.20% [1]
东方嘉盛(002889) - 2025年第二次临时股东大会决议公告
2025-10-15 10:15
深圳市东方嘉盛供应链股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 特别提示 一、会议召开情况 证券代码:002889 证券简称:东方嘉盛 公告编号:2025-034 二、会议出席情况 (一)股东出席的总体情况 参加本次股东大会现场会议和网络投票表决的股东及股东代理人共 215 人, 代表有表决权的公司股份数合计为 267,314,409 股,占公司有表决权股份总数 377,667,472 股的 70.7804%。其中:通过现场投票的股东共 9 人,代表有表决权 的公司股份数合计为 266,460,656 股,占公司有表决权股份总数 377,667,472 股的 70.5543%;通过网络投票的股东共 206 人,代表有表决权的公司股份数合计为 853,753 股,占公司有表决权股份总数 377,667,472 股的 0.2261%。 (二)中小股东出席的总体情况 1、 本次股东大会不存在否决议案的情形。 2、 本次股东大会不涉及变更以往股东大会已通过的决议。 1、 召开时间:2025 年 10 月 15 ...
东方嘉盛(002889) - 北京海润天睿律师事务所关于深圳市东方嘉盛供应链股份有限公司2025年第二次临时股东大会法律意见书
2025-10-15 10:15
北京海润天睿律师事务所(以下简称"本所")接受深圳市东方嘉盛供应 链股份有限公司(以下简称"公司")的委托,指派本所律师出席公司 2025 年 第二次临时股东大会(以下简称"本次股东大会"),并依据《中华人民共和国公 司法》(以下简称"《公司法》")、《中华人民共和国证券法》(以下简称"《证券 法》")、《上市公司股东会规则》(以下简称"《股东会规则》")、《公司章程》及 其他相关法律、法规的规定,就公司本次股东大会的召集、召开程序、出席会议 人员的资格、召集人资格、表决程序及表决结果等有关事宜出具本法律意见书。 关于本法律意见书,本所及本所律师谨作如下声明: 北京海润天睿律师事务所 关于深圳市东方嘉盛供应链股份有限公司 2025 年第二次临时股东大会的法律意见书 致:深圳市东方嘉盛供应链股份有限公司 1. 在本法律意见书中,本所及本所律师仅就本次股东大会的召集及召开程 序、出席会议人员及召集人的资格、表决程序及表决结果进行核查和见证并发表 法律意见,不对本次股东大会的议案内容及其所涉及的事实和数据的完整性、真 实性和准确性发表意见。 2. 本所及本所律师依据《证券法》《律师事务所从事证券法律业务管理办法》 ...